-
June 29, 2018 Lupin and MCGM Unite to launch Anti-TB Campaign in Mumbai
-
June 29, 2018 Lupin announces tie-up with European Association of Urology (EAU)
-
June 28, 2018 Lupin and Mylan Partner to Commercialize Enbrel® (Etanercept) Biosimilar
-
June 18, 2018 Lupin and Nichi-Iko announce strategic partnership for commercialization of biosimilar Etanercept in Japan
-
June 14, 2018 Lupin receives FDA approval for generic Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets and Levomefolate Calcium Tablets, 3 mg/0.02 mg/0.451 mg and 0.451 mg
-
June 13, 2018 Lupin launches generic Tobramycin Inhalation Solution USP in the US
-
June 4, 2018 Lupin launches generic Methylergonovine Maleate Tabs USP in the US
-
June 4, 2018 Lupin receives FDA approval for generic Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1mg/gram
-
May 31, 2018 Lupin launches Solosec™ (secnidazole) 2g Oral Granules in the US
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications